skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Metastasis remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

Tanjak, Pariyada ; Suktitipat, Bhoom ; Vorasan, Nutchavadee ; Juengwiwattanakitti, Panudeth ; Thiengtrong, Benjarat ; Songjang, Cholticha ; Therasakvichya, Suwanit ; Laiteerapong, Somsri ; Chinswangwatanakul, Vitoon

BMC cancer, 2021-09, Vol.21 (1), p.1-1045, Article 1045 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine

Kanzaki, Ryu ; Pietras, Kristian

Cancer science, 2020-08, Vol.111 (8), p.2708-2717 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
3
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Rotte, Anand

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.255-255, Article 255 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Glaviano, Antonino ; Foo, Aaron S. C ; Lam, Hiu Y ; Yap, Kenneth C. H ; Jacot, William ; Jones, Robert H ; Eng, Huiyan ; Nair, Madhumathy G ; Makvandi, Pooyan ; Geoerger, Birgit ; Kulke, Matthew H ; Baird, Richard D ; Prabhu, Jyothi S ; Carbone, Daniela ; Pecoraro, Camilla ; Teh, Daniel B. L ; Sethi, Gautam ; Cavalieri, Vincenzo ; Lin, Kevin H ; Javidi-Sharifi, Nathalie R ; Toska, Eneda ; Davids, Matthew S ; Brown, Jennifer R ; Diana, Patrizia ; Stebbing, Justin ; Fruman, David A ; Kumar, Alan P

Molecular cancer, 2023-08, Vol.22 (1), p.1-138, Article 138 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
Long non‑coding RNA GAS5 in human cancer (Review)
Long non‑coding RNA GAS5 in human cancer (Review)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long non‑coding RNA GAS5 in human cancer (Review)

Yang, Xiaoyan ; Xie, Zhizhong ; Lei, Xiaoyong ; Gan, Runliang

Oncology letters, 2020-09, Vol.20 (3), p.2587-2594

Athens: Spandidos Publications

Texto completo disponível

Citações Citado por
6
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Zhao, Pengfei ; Li, Li ; Jiang, Xiaoyue ; Li, Qin

Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Material Type:
Artigo 		Adicionar ao Meu Espaço

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

Wagner, Anna Dorothea ; Grabsch, Heike I ; Mauer, Murielle ; Marreaud, Sandrine ; Caballero, Carmela ; Thuss-Patience, Peter ; Mueller, Lothar ; Elme, Annelie ; Moehler, Markus Hermann ; Martens, Uwe ; Kang, Yoon-Koo ; Rha, Sun Young ; Cats, Annemieke ; Tokunaga, Masanori ; Lordick, Florian

BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer

Ham, In-Hye ; Oh, Hye Jeong ; Jin, Hyejin ; Bae, Cheong A ; Jeon, Sang-Min ; Choi, Kyeong Sook ; Son, Sang-Yong ; Han, Sang-Uk ; Brekken, Rolf A ; Lee, Dakeun ; Hur, Hoon

Molecular cancer, 2019-03, Vol.18 (1), p.68-68, Article 68 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
9
Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway
Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway
Material Type:
Artigo 		Adicionar ao Meu Espaço

Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway

Zhang, Xing ; Wang, Sen ; Wang, Haixiao ; Cao, Jiacheng ; Huang, Xiaoxu ; Chen, Zheng ; Xu, Penghui ; Sun, Guangli ; Xu, Jianghao ; Lv, Jialun ; Xu, Zekuan

Molecular cancer, 2019-02, Vol.18 (1), p.20-20, Article 20 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Davis, Andrew A. ; Patel, Vaibhav G.

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.278-278, Article 278 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (71.368)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (79.151)
  2. Newsletter Articles  (20.206)
  3. magazinearticle  (140)
  4. Livros  (65)
  5. Book Chapters  (32)
  6. Reports  (20)
  7. Dissertações  (17)
  8. Artigos de Jornal  (12)
  9. Anais de Congresso  (5)
  10. Resenhas  (4)
  11. Conjunto de Dados  (1)
  12. Web Resources  (1)
  13. Mais opções open sub menu

Assunto 

  1. Science & Technology  (76.805)
  2. Life Sciences & Biomedicine  (74.722)
  3. Tumors  (38.673)
  4. Humans  (38.183)
  5. Cancer Therapies  (32.320)
  6. Medical Prognosis  (31.853)
  7. Cancer  (29.478)
  8. Patients  (29.027)
  9. Chemotherapy  (27.384)
  10. Metastases  (25.423)
  11. Breast Cancer  (22.476)
  12. Female  (21.414)
  13. Proteins  (18.176)
  14. Care And Treatment  (17.407)
  15. Gene Expression  (16.908)
  16. Prognosis  (16.907)
  17. Male  (15.708)
  18. Surgery  (15.349)
  19. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1986  (21)
  2. 1986Até1994  (161)
  3. 1995Até2003  (1.118)
  4. 2004Até2013  (8.411)
  5. Após 2013  (89.979)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (99.509)
  2. Japonês  (10.725)
  3. Chinês  (103)
  4. Turco  (93)
  5. Alemão  (62)
  6. Norueguês  (46)
  7. Português  (16)
  8. Espanhol  (14)
  9. Francês  (13)
  10. Russo  (8)
  11. Polonês  (6)
  12. Italiano  (2)
  13. Coreano  (2)
  14. Africâner  (1)
  15. Catalão  (1)
  16. Holandês  (1)
  17. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.